학술논문

First-Line Lorlatinib Versus Crizotinib in ALK-Positive NSCLC: Japanese Subgroup Analysis of CROWN
Document Type
Article
Source
In JTO Clinical and Research Reports April 2023 4(4)
Subject
Language
ISSN
2666-3643